Hyun D. Kim
Corporate Officer/Principal bei EMBER THERAPEUTICS, INC.
Profil
Hyun D.
Kim is currently working as Vice President-Clinical Development at Ember Therapeutics, Inc. He previously worked as Director-Product Development at Anika Therapeutics, Inc., Director-Research & Development at Transport Pharmaceuticals, Inc., Director-Research & Development at Olympus Biotech Corp.
(United States), and Vice President-Clinical Development at Ember Therapeutics, Inc. Dr. Kim completed his undergraduate, graduate, and doctorate degrees from Brown University.
Aktive Positionen von Hyun D. Kim
| Unternehmen | Position | Beginn |
|---|---|---|
| EMBER THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Hyun D. Kim
| Unternehmen | Position | Ende |
|---|---|---|
| Olympus Biotech Corp. (United States) | Technik-/Wissenschafts-/F&E-Leiter | - |
| ANIKA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Transport Pharmaceuticals, Inc.
 Transport Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Transport Pharmaceuticals, Inc. engaged in the development of medical products for the treatment of multiple dermatological diseases. It developed iontophoretic technique to effect trans-dermal drug delivery for a number of dermatological conditions. The company was founded by Dennis I. Goldberg in 1999 and was headquartered in Framingham, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ember Therapeutics, Inc. /Old/
 Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Ausbildung von Hyun D. Kim
| Brown University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EMBER THERAPEUTICS, INC. | Health Technology |
| ANIKA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | Health Technology |
Transport Pharmaceuticals, Inc.
Transport Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Transport Pharmaceuticals, Inc. engaged in the development of medical products for the treatment of multiple dermatological diseases. It developed iontophoretic technique to effect trans-dermal drug delivery for a number of dermatological conditions. The company was founded by Dennis I. Goldberg in 1999 and was headquartered in Framingham, MA. | Health Technology |
| Olympus Biotech Corp. (United States) |
